Search
for

    Sort by

    Research 30 of 85

    1. Pharmacist Intervention in Fluvoxamine Induced Alopecia: A Case Report in Tertiary Care Teaching Hospital Indian Journal of Pharmacy Practice · 2016
    2. Trichotillomania with trichotillophagia, Progressive Psychosis-Like Symptoms and Disinhibition, Following Suspected Frontal Traumatic Brain Injury: A Case Report 2026
    3. TACRINE 2004
    4. An update of anti-viral treatment of COVID-19 Turkish Journal of Medical Sciences · 2021 · 51 citations
    5. The Need for Speed and Efficiency: A Brief Review of Small Molecule Antivirals for COVID-19 Frontiers in drug discovery · 2022 · 6 citations
    6. Can male-pattern baldness be prevented? The Lancet · 1997 · 3 citations
    7. News in brief The Lancet · 1997
    8. First reboxetine trial results reported The Lancet · 1997
    9. Adverse Side Effects of 5α‐Reductase Inhibitors Therapy: Persistent Diminished Libido and Erectile Dysfunction and Depression in a Subset of Patients The Journal of Sexual Medicine · 2010 · 223 citations
    10. Neurosteroidogenesis Today: Novel Targets for Neuroactive Steroid Synthesis and Action and Their Relevance for Translational Research Journal of Neuroendocrinology · 2015 · 123 citations
    11. Finasteride induced depression: a prospective study BMC clinical pharmacology · 2006 · 99 citations
    12. Production of 5α-Reduced Neurosteroids Is Developmentally Regulated and Shapes GABA<sub>A</sub>Miniature IPSCs in Lamina II of the Spinal Cord Journal of Neuroscience · 2004 · 88 citations
    13. The Dark Side of 5α-Reductase Inhibitors' Therapy: Sexual Dysfunction, High Gleason Grade Prostate Cancer and Depression Korean Journal of Urology · 2014 · 75 citations
    14. Relationships between cerebrospinal fluid GABAergic neurosteroid levels and symptom severity in men with PTSD Psychoneuroendocrinology · 2018 · 59 citations
    15. Cutaneous effects of the most commonly used antidepressant medication, the selective serotonin reuptake inhibitors Journal of The American Academy of Dermatology · 2006 · 55 citations
    16. Adverse Cutaneous Reactions to Antidepressants American Journal of Clinical Dermatology · 2002 · 44 citations
    17. Psychodermatology Archives of Dermatology · 1992 · 41 citations
    18. Realising the therapeutic potential of neuroactive steroid modulators of the GABAA receptor Neurobiology of Stress · 2019 · 40 citations
    19. Psychocutaneous disease Journal of The American Academy of Dermatology · 2017 · 38 citations
    20. Testosterone Improves Antidepressant‐Emergent Loss of Libido in Women: Findings from a Randomized, Double‐Blind, Placebo‐Controlled Trial The Journal of Sexual Medicine · 2014 · 36 citations
    21. The placebo effect and randomized trials: analysis of conventional medicine Urologic clinics of North America · 2002 · 26 citations
    22. Psychodermatology Advances in Psychosomatic Medicine · 2015 · 25 citations
    23. Pediatric Psychocutaneous Disorders American Journal of Clinical Dermatology · 2011 · 22 citations
    24. Consequences of steroid-5α-reductase deficiency and inhibition in vertebrates General and Comparative Endocrinology · 2020 · 21 citations
    25. The pathophysiology of delayed ejaculation Translational Andrology and Urology · 2016 · 21 citations
    26. Long COVID syndrome: An unfolding enigma The Indian Journal of Medical Research · 2024 · 17 citations
    27. Obsessive-compulsive disorder in dermatology Journal der Deutschen Dermatologischen Gesellschaft · 2015 · 15 citations
    28. Psychoactive drugs and skin Journal of the European Academy of Dermatology and Venereology · 2003 · 12 citations
    29. Antidepressant-like effect of fluoxetine may depend on translocator protein activity and pretest session duration in forced swimming test in mice Behavioural Pharmacology · 2017 · 7 citations
    30. Adverse cutaneous effects of psychotropic medications Expert Review of Dermatology · 2013 · 6 citations